In our family, the first diagnostic tier was an NGS-Panel for Arrhythmias (48 genes), which detected two heterozygous variants of uncertain significance in SCN5A and CACNA1D. At this point, the PPA2-related disease had not been reported. This evidence concerns the gene SCN5A and cardiac arrhythmia.